» Articles » PMID: 27594870

Evolvement of Left Ventricular Assist Device: the Implications on Heart Failure Management

Overview
Specialty Geriatrics
Date 2016 Sep 6
PMID 27594870
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF) is a potentially fatal disease that affects increasing number of people worldwide. Although heart transplant is the "gold standard" therapy for HF, due to the limited availability of organs, many patients died when waiting for the transplant. Left ventricular assist device (LVAD), as a mechanical circulatory support, has become a new light for patients with HF. With the technical advancements, LVADs work not only as a bridge to transplant, but also assist heart recovery and even as a destination therapy in long-term treatment. This observation paper reviewed the development of LVAD and its clinical roles. The challenges and possible solutions in nursing care for patients with LVAD at different stage of implantation were discussed. The healthcare professionals could obtain a better understanding about the LVAD treatment for HF patients.

Citing Articles

Outcomes of Left Ventricular Assist Devices as Destination Therapy: A Systematic Review with Meta-Analysis.

Khoufi E Life (Basel). 2025; 15(1).

PMID: 39859993 PMC: 11767145. DOI: 10.3390/life15010053.


Left Ventricular Assist Device in Advanced Refractory Heart Failure: A Comprehensive Review of Patient Selection, Surgical Approaches, Complications and Future Perspectives.

Al Hazzouri A, Attieh P, Sleiman C, Hamdan R, Ghadieh H, Harbieh B Diagnostics (Basel). 2024; 14(22).

PMID: 39594146 PMC: 11593065. DOI: 10.3390/diagnostics14222480.


Outcome Through the Years of Left-Ventricular Assist Devices Therapy for End-Stage Heart Failure: A Review.

Tropea I, Cresce G, Sanesi V, Salvador L, Zoni D J Clin Med. 2024; 13(21).

PMID: 39518766 PMC: 11546408. DOI: 10.3390/jcm13216622.


Nine Years of Continuous Flow LVAD (HeartMate 3): Survival and LVAD-Related Complications before and after Hospital Discharge.

Sandoval Boburg R, Marinos S, Baumgaertner M, Rustenbach C, Salewski C, Doll I J Cardiovasc Dev Dis. 2024; 11(10).

PMID: 39452272 PMC: 11508271. DOI: 10.3390/jcdd11100301.


Pre-left ventricular assist device endoscopic evaluation does not reduce the risk of later gastrointestinal bleeding: a multicenter study.

Peng J, Devalaraju S, Azab M, Cates W, Stone M, Reichstein J Ann Gastroenterol. 2024; 37(3):313-320.

PMID: 38779638 PMC: 11107400. DOI: 10.20524/aog.2024.0878.


References
1.
Zhang J, Liu X, Liu Z, Li Y, Han Z, Xu J . [In vivo evaluation of magnetic and hydrodynamic suspension centrifugal ventricular assist device]. Zhonghua Yi Xue Za Zhi. 2014; 94(22):1740-3. View

2.
Ammirati E, Oliva F, Cannata A, Contri R, Colombo T, Martinelli L . Current indications for heart transplantation and left ventricular assist device: a practical point of view. Eur J Intern Med. 2014; 25(5):422-9. DOI: 10.1016/j.ejim.2014.02.006. View

3.
Gu K, Chang Y, Gao B, Wan F, Loisance D, Zeng Y . Development of ventricular assist devices in China: present status, opportunities and challenges. Eur J Cardiothorac Surg. 2014; 46(2):179-85. DOI: 10.1093/ejcts/ezu020. View

4.
Stewart G, Givertz M . Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation. 2012; 125(10):1304-15. DOI: 10.1161/CIRCULATIONAHA.111.060830. View

5.
Casida J, Marcuccilli L, Peters R, Wright S . Lifestyle adjustments of adults with long-term implantable left ventricular assist devices: a phenomenologic inquiry. Heart Lung. 2011; 40(6):511-20. DOI: 10.1016/j.hrtlng.2011.05.002. View